Veterinary Clostridium Vaccine Market Size To Expand at a Notable CAGR Of 4.2% During 2022 - 2030

Pune, India, February, 2021/MRFR Press Release/- Market Research Future has published a half-cooked research report on the Global Veterinary clostridium vaccine Market.

Market Highlights

The global veterinary clostridium vaccine anticipated to have held a market value of USD USD 423.29 Million by 2030 and is expected to grow at a CAGR of 4.2% during the forecast period.

Clostridium bacteria is an anaerobic in nature and widely found in soil and gut of humans and animals. Vaccination play important role in protection of animals against clostridial diseases. The vaccines are more commonly used for animals such as bovine, ovine, swine, caprine, poultry, and other animals. Wide variety of vaccines is available in the treatment of clostridial diseases such as single and combination vaccines. The combination vaccines consist of bacterins, toxoids, or mixtures of bacterins and toxoids. The veterinary hospital, veterinary clinic, veterinary research institute, and retail pharmacy are the major distribution channel for the veterinary clostridium vaccine products.

The increasing awareness pertaining to zoonotic diseases, rising incidence rate of clostridium family diseases, increased awareness relating animal-derived products, and increase in disposable income are expected to drive the growth of market. However, side effects associated with vaccines and high cost of the treatment hamper the market growth over the forecast period.

Regional Analysis

Geographically, the Americas is expected to dominate the global veterinary clostridium vaccine market owing to the presence of well-established players, increased awareness pertaining to zoonotic diseases, rising incidence rate of clostridium family diseases, increased awareness relating animal-derived products, and increase in disposable income. Europe is expected to hold the second largest position in the global veterinary clostridium vaccine market. Asia-Pacific is expected to be the fastest growing market owing to the increasing awareness about veterinary clostridium vaccine products and increase in disposable income. Furthermore, the Middle East and Africa region is expected to account for the least market share in the global veterinary clostridium vaccine market.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Veterinary Clostridium Vaccine Market Research Report

Segmentation

The global veterinary clostridium vaccine market has been segmented into animal type and distribution channels.

Based on animal type, veterinary clostridium vaccine market is segmented into bovine, ovine, swine, caprine, poultry, and others. The bovine segment is expected to account for the largest share segment of the veterinary clostridium vaccine market in 2017.

Based on distribution channels, veterinary clostridium vaccine market is segmented into veterinary hospital, veterinary clinic, veterinary research institute, and retail pharmacy. The veterinary hospital segment is expected to account for the largest share segment of the veterinary clostridium vaccine market in 2017.

Key Players

Some of the prominent players in the global veterinary clostridium vaccine market are Merck & Co., Inc. (US), Ceva Santé Animale (France), Boehringer Ingelheim International GmbH (Germany), Colorado Serum Company (US), Virbac (Australia), Valneva SE (France), Zoetis (US), Elanco Animal Health (US), and Bayer AG (Germany).